BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37553777)

  • 1. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region.
    Waked I; Alsammany S; Tirmazy SH; Rasul K; Bani-Issa J; Abdel-Razek W; Omar A; Shafik A; Eid S; Abdelaal A; Hosni A; Esmat G
    Liver Int; 2023 Oct; 43(10):2062-2077. PubMed ID: 37553777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian recommendations for the management of hepatocellular carcinoma: a consensus statement.
    Lubel JS; Roberts SK; Strasser SI; Thompson AJ; Philip J; Goodwin M; Clarke S; Crawford DH; Levy MT; Shackel N
    Med J Aust; 2021 Jun; 214(10):475-483. PubMed ID: 33314233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
    Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
    Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.
    Thomas MB; Jaffe D; Choti MM; Belghiti J; Curley S; Fong Y; Gores G; Kerlan R; Merle P; O'Neil B; Poon R; Schwartz L; Tepper J; Yao F; Haller D; Mooney M; Venook A
    J Clin Oncol; 2010 Sep; 28(25):3994-4005. PubMed ID: 20679622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and therapeutic management of hepatocellular carcinoma.
    Bellissimo F; Pinzone MR; Cacopardo B; Nunnari G
    World J Gastroenterol; 2015 Nov; 21(42):12003-21. PubMed ID: 26576088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.
    Loomba R; Lim JK; Patton H; El-Serag HB
    Gastroenterology; 2020 May; 158(6):1822-1830. PubMed ID: 32006545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
    Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
    World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: the management of hepatocellular carcinoma.
    Cabrera R; Nelson DR
    Aliment Pharmacol Ther; 2010 Feb; 31(4):461-76. PubMed ID: 19925500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System.
    Kikuchi L; Oliveira CP; Alvares-da-Silva MR; Tani CM; Diniz MA; Stefano JT; Chagas AL; Alencar RS; Vezozzo DC; Santos GR; Campos PB; Alves VA; Ratziu V; Carrilho FJ
    Am J Clin Oncol; 2016 Oct; 39(5):428-32. PubMed ID: 25268068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
    Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
    Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.
    Mak LY; Cruz-Ramón V; Chinchilla-López P; Torres HA; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Bailey HH; Méndez-Sánchez N; Yuen MF; Hwang JP
    Am Soc Clin Oncol Educ Book; 2018 May; 38():262-279. PubMed ID: 30231359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis.
    Tovo CV; de Mattos AZ; Coral GP; Sartori GDP; Nogueira LV; Both GT; Villela-Nogueira CA; de Mattos AA
    World J Gastroenterol; 2023 Jan; 29(2):343-356. PubMed ID: 36687125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mexican consensus on the diagnosis and management of hepatocellular carcinoma.
    González Huezo MS; Sánchez Ávila JF; ; ; ; ; ;
    Rev Gastroenterol Mex; 2014; 79(4):250-62. PubMed ID: 25487133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC).
    Park JW; Amarapurkar D; Chao Y; Chen PJ; Geschwind JF; Goh KL; Han KH; Kudo M; Lee HC; Lee RC; Lesmana LA; Lim HY; Paik SW; Poon RT; Tan CK; Tanwandee T; Teng G; Cheng AL
    Liver Int; 2013 Mar; 33(3):327-37. PubMed ID: 23331661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia.
    Alolyan A; Alshammari K; Arabi M; Alshehri A; Alsuhaibani H; Ibnshamsah F; Alsharm A; Mahrous M; Al Zanbagi A; Hassanain M; Bazarbashi S
    J Hepatocell Carcinoma; 2024; 11():349-362. PubMed ID: 38385059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India.
    Musunuri B; Shetty S; Bhat G; Udupa K; Pai A
    Indian J Gastroenterol; 2022 Apr; 41(2):127-134. PubMed ID: 35226292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
    Anastasopoulos NT; Lianos GD; Tatsi V; Karampa A; Goussia A; Glantzounis GK
    Expert Rev Gastroenterol Hepatol; 2020 Nov; 14(11):1025-1033. PubMed ID: 32746645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
    Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
    World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.